Ginsenoside Rk3

Ginsenoside Rk3 (CAS No.: 364779-15-7) is a bioactive compound extracted from the roots of Panax ginseng, widely studied for its potential applications in the realm of biomedical research and drug discovery. It plays a significant role in the modulation of inflammatory responses, primarily through the inhibition of TNF-α-induced NF-κB transcriptional activity, with an inhibitory concentration (IC50) valued at 14.24±1.30 μM, suggesting its efficacy in the low micromolar range. This ginsenoside is categorizable as a saponin, known for its role in disrupting cellular signaling pathways linked to inflammation and oxidative stress. In vitro studies frequently utilize hepatocellular carcinoma cell lines such as HepG2 to evaluate its pharmacological activity, providing insights into its mechanistic pathways. Its relevance extends to compound preparations targeting ischemic heart conditions, reflecting its impact on cardiovascular injury models in preclinical research. Ginsenoside Rk3's applications in drug screening processes highlight its importance as a research tool for exploring cytokine pathways and cellular apoptosis mechanisms, with concentrations adapted to specific experimental frameworks. Through advancing the understanding of its molecular interactions, Ginsenoside Rk3 supports the ongoing pursuit of novel therapeutic candidates in the scientific community.